Financhill
Back

Trinity Biotech PLC Quote, Financials, Valuation and Earnings

Trinity Biotech PLC Price Quote

$2.14
+0.01 (+0.47%)
(Updated: July 1, 2024 at 6:55 PM ET)

Trinity Biotech PLC Key Stats

Sell
32
Trinity Biotech PLC (TRIB) is a Sell

Day range:
$2.01 - $2.29
52-week range:
$1.49 - $5.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.27
P/B ratio:
0%

Volume:
35.9K
Avg. volume:
63.6K
1-year change:
-54.68%
Market cap:
$20.2M
Revenue:
$56.8M
EPS:
$-23.5

How Much Does Trinity Biotech PLC Make?

Is Trinity Biotech PLC Growing As A Company?

  • What Is Trinity Biotech PLC's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.01%
  • What Is Trinity Biotech PLC's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Trinity Biotech PLC Stock Price Performance

What Is Trinity Biotech PLC 52-Week High & Low?

Trinity Biotech PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Trinity Biotech PLC?

Is Trinity Biotech PLC Cash Flow Positive?

  • What Is TRIB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$11.7M
  • What Is Trinity Biotech PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.2M
  • What Is Trinity Biotech PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $12.1M

Trinity Biotech PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    TRIB return on invested capital is -49.33%
  • What Is Trinity Biotech PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -28.59%
  • What Is TRIB Return On Equity?
    ROE is a measure of profitability and is 0%

Trinity Biotech PLC Earnings Date & Stock Price

Trinity Biotech PLC Competitors

  • Who Are Trinity Biotech PLC's Competitors?
    Below is a list of companies who compete with Trinity Biotech PLC or are related in some way:
    • Amarin Corp PLC (AMRN)
    • Avadel Pharmaceuticals PLC (AVDL)
    • Perspective Therapeutics Inc (CATX)
    • Medtronic PLC (MDT)
    • Xtant Medical Holdings Inc (XTNT)

Trinity Biotech PLC Dividend Yield

Data Unavailable

Trinity Biotech PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -0.84% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 15.00
Upside from Last Price: 604.23%

Major Shareholders

  • How many TRIB shares are owned by institutional investors?
    3M TRIB shares are owned by institutional investors
  • How many TRIB shares are owned by insiders?
    8.8M TRIB shares are owned by insiders